Announcements
Sidley Advises PhaseV in Its US$50 Million Series A Financing
May 14, 2025
Sidley advised PhaseV Trials Inc., a leader in AI/ML-driven clinical development, in its US$50 million Series A financing round. The round was co-led by Accel and Insight Partners, with participation from Viola Ventures, Exor Ventures, and LionBird.
For additional information, please refer to the press release.
The Sidley team was led by Dr. Idan Netser and Jake Funk (Emerging Companies and Venture Capital).
連絡先
得意分野
Suggested News & Insights
2026 Emerging Companies & Venture Capital SummitWednesday, May 20, 2026International Emergency Economic Powers Act Tariff Refund Claims: Key Considerations for Lenders, Borrowers, and Claims PurchasersApril 30, 2026Chambers Global Practice Guides – Corporate M&A 2026April 24, 2026Sidley Represents Valius Sciences in Financing Raising More Than US$10 Million for Future Cancer DiagnosticsApril 23, 2026New U.S. SEC Exemptive Order on Tender Offers Will Meaningfully Streamline Certain Liquidity TransactionsApril 21, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory